Skip to content
Back to News Hub
CharitiesAidWelfare, Medical Health Aged Care

TIME TO GIVE A $#*! – 2 MONTHS TO GO – SAVE THE DATE

Bowel Cancer Australia < 1 mins read

TIME TO GIVE A $#*!

2 MONTHS TO GO UNTIL

Bowel Cancer Awareness Month

 

June is Bowel Cancer Awareness Month - Bowel Cancer Australia’s signature event to raise awareness of Australia’s second deadliest cancer and funds for the nation’s leading community-funded charity.

 

Australia has the highest rates of early-onset bowel cancer in the world and it is the deadliest cancer for people aged 25-54.

 

Support Bowel Cancer Australia in championing what matters most to people impacted by bowel cancer and empowering everyone affected to live their best life.

bowelcanceraustralia.org/facts
Helpline: 1800 727 336 (SCREEN)


Contact details:

For an interview with a medical expert or patient, please contact:

Stephanie Bansemer-Brown, Bowel Cancer Australia

[email protected]   |   0412 915 797

Media

More from this category

  • Medical Health Aged Care
  • 25/04/2025
  • 18:11
Elixir Medical Corporation

Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia

First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea.Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an external energy source.MILPITAS, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced the first clinical use of its LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in the Asia Pacific region, marking a significant milestone in the device's global introduction. The procedures were successfully performed…

  • Medical Health Aged Care
  • 25/04/2025
  • 09:59
Monash University

Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity: study

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found. Metformin, which is commonly prescribed to treat type 2 diabetes, reduced knee arthritis pain over six months in a clinical trial published in JAMA. The randomised clinical trial looked at whether metformin, compared to a placebo, reduced knee pain in patients withsymptomatic knee osteoarthritis (knee OA) andoverweight or obesity. The research was performed entirely as a community-based study using telehealth. Some of the 107 participants with pain from knee osteoarthritis (73…

  • CharitiesAidWelfare, Federal Election
  • 25/04/2025
  • 06:00
Pacific Friends of Global Health

US cuts to aid funding put Indo-Pacific at risk of malaria resurgence

On World Malaria Day, 25 AprilPacific Friends of Global Health and the Australian Global Health Alliance are raising the alarm over the potential for a resurgence of malaria throughout the Indo-Pacific region as a result of the US government’s decision to cut around 90% of funding for global public health programs. A new report, Red Alert: Malaria risks to the Indo-Pacific following US aid funding cuts, outlines the success of US and Australian investment in programs to tackle malaria throughout the Indo-Pacific since 2002. This investment has seen incidence rates across the region fall from 18 per 1000 people in…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.

Book a demo Explore our plans